Made in Ontario by AA Pharma, Desmopressin is a drug delivered in nasal spray form to combat the effects of diabetes ...

Immedica Pharma today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval of Loargys® (pegzilarginase-nbln), an arginine specific enzyme indicated for the ...

LOARGYS is the first and only therapy proven to lower arginine in patients 2 years of age and older living with ARG1-D -- ARG1-D is an ultra-rare, debilitating, and progressive metabolic disease ...

Phase 3 PEACE trial data support the accelerated approval of Loargys for the treatment of arginase 1 deficiency in pediatric and adult patients.

Liquid alternative to desmopressin tablets allows for more precise dosing ...

Four years after the FDA issued its most heavy-handed form of a rejection to the prior company behind pegzilarginase, the U.S. regulator has now given the treatment a thumbs-up. | Four years after the ...

Revolutionary Liquid Pump Product for Optimal Performance Tempe, Aruba - February 25, 2026 / Performance Supplements / ...

By Kamal Choudhury Feb 25 (Reuters) - The U.S. Food and Drug Administration on Wednesday approved Eton Pharmaceuticals' first-of-its-kind liquid therapy for a rare hormonal disorder, offering a more ...

BBC Radio 2's Sara Cox has shared the Dr Vegan Women's ProMulti supplement she takes daily, saying customers report it makes ...

Clinicians now have an FDA-approved liquid desmopressin option for central diabetes insipidus, designed for dosing consistency across the age spectrum.

"I genuinely haven't needed to redo my Botox for nearly two months longer than usual because of this new full range. After ...